Evidence map›Paper›PMID 36190439›Full record

ReviewMuscle & nerve2023

Peripheral neuropathies associated with DNA repair disorders.

Melissa Maguina, Peter B Kang, Ang-Chen Tsai, Christina A Pacak

Open access · hybridAbstract readReview
In one paragraph

Review in Muscle & nerve, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. SIRT4 in ageing.Biogerontology · 2023
    Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Melissa MaguinaMedical Education Program, Nova Southeastern University, Fort Lauderdale, Florida.
Peter B KangDepartment of Neurology, Paul and Sheila Wellstone Muscular Dystrophy Center, University of Minnesota Medical School, Minneapolis, Minnesota.ORCID https://orcid.org/0000-0002-4270-7325
Ang-Chen TsaiDepartment of Pediatrics, University of Florida College of Medicine, Gainesville, Florida.
Christina A PacakDepartment of Neurology, Paul and Sheila Wellstone Muscular Dystrophy Center, University of Minnesota Medical School, Minneapolis, Minnesota.ORCID https://orcid.org/0000-0002-7430-124X
University of Minnesota · USNova Southeastern University · USUniversity of Florida · US

Funding

Optimized Production and Validation of Rationally Designed AAV Vectors for Cockayne Syndrome Gene TherapyR01FD007483 · FDA · UNIVERSITY OF MINNESOTA · PI ASLANIDI, GEORGE V, PACAK, CHRISTINA A. · 2021 to 2023
$1.8M
FDA HHS R01 FD007483
6 · The paper itself

Abstract

Repair of genomic DNA is a fundamental housekeeping process that quietly maintains the health of our genomes. The consequences of a genetic defect affecting a component of this delicate mechanism are quite harmful, characterized by a cascade of premature aging that injures a variety of organs, including the nervous system. One part of the nervous system that is impaired in certain DNA repair disorders is the peripheral nerve. Chronic motor, sensory, and sensorimotor polyneuropathies have all been observed in affected individuals, with specific physiologies associated with different categories of DNA repair disorders. Cockayne syndrome has classically been linked to demyelinating polyneuropathies, whereas xeroderma pigmentosum has long been associated with axonal polyneuropathies. Three additional recessive DNA repair disorders are associated with neuropathies, including trichothiodystrophy, Werner syndrome, and ataxia-telangiectasia. Although plausible biological explanations exist for why the peripheral nerves are specifically vulnerable to impairments of DNA repair, specific mechanisms such as oxidative stress remain largely unexplored in this context, and bear further study. It is also unclear why different DNA repair disorders manifest with different types of neuropathy, and why neuropathy is not universally present in those diseases. Longitudinal physiological monitoring of these neuropathies with serial electrodiagnostic studies may provide valuable noninvasive outcome data in the context of future natural history studies, and thus the responses of these neuropathies may become sentinel outcome measures for future clinical trials of treatments currently in development such as adeno-associated virus gene replacement therapies.

Indexed as

Cockayne SyndromePeripheral Nervous System DiseasesPolyneuropathiesXeroderma PigmentosumDNA RepairHumansataxia telangiectasiaCockayne syndromeDNA repair disordersneuropathiesperipheral neuropathytrichothiodystrophyWerner syndromexeroderma pigmentosum

Identifiers

PMID36190439
PMCPMC10075233
OpenAlexW4300688148

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.